Search all trials

Find therapies in clinical trials near you – page 33

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Neuroblastoma

Recruiting

InvestigationalNo placebo

Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Naxitamab

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drug

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Coagulation factor X level

Recruiting

InvestigationalNo placebo

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:VMX-C001

Contact Research Centre

Bladder cancer

Recruiting

Registered drugNo placebo

Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Acute myocardial infarction+1

Recruiting

Registered drugNo placebo

Bisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bisoprolol

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

BMS-986525 Alone and with Nivolumab in Patients with Relapsed or Refractory Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Investigational

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Nipocalimab

Contact Research Centre

Chronic myeloid leukaemia

Recruiting

Registered drugNo placebo

Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

Registered drugNo placebo

France

Participants:0–17 years
Substances:Asciminib Hydrochloride

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

InvestigationalNo placebo

JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Pancreatic failure

Recruiting

InvestigationalNo placebo

NHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Amylase

Contact Research Centre

Find therapies in clinical trials near you – page 33

10 273 trials match your criteria

Hormone-dependent prostate cancer

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Neuroblastoma

Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

Colorectal cancer metastatic

INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Non-small cell lung cancer

Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Coagulation factor X level

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

Bladder cancer

Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

Acute myocardial infarction+1

Bisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation

Small cell lung cancer

BMS-986525 Alone and with Nivolumab in Patients with Relapsed or Refractory Small Cell Lung Cancer

Systemic lupus erythematosus

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Chronic myeloid leukaemia

Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

Plasma cell myeloma refractory

JNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments

Pancreatic failure

NHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.